Last reviewed · How we verify
Chemoprevention Efficacy Study Nigeria
The study aims to assess the chemoprevention efficacy of Sulfadoxine-Pyrimethamine and Amodiaquine (SPAQ) used in standard age-based dosing regimens used in Seasonal Malaria Chemoprevention (SMC) and SPAQ resistance marker prevalences and assocations among children 3 - 59 months in Sokoto and Kwara States, Nigeria.
Details
| Lead sponsor | Malaria Consortium |
|---|---|
| Phase | PHASE4 |
| Status | UNKNOWN |
| Enrolment | 800 |
| Start date | Fri Jul 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed May 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Malaria
Interventions
- Standard age based SPAQ administration for SMC
Countries
Nigeria